Chien-Chung Lin

15PUBLICATIONS
33CO-AUTHORS
Molecular targetsPredictive and prognostic markersFluid-structure interaction and aeroacousticsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Dec 11, 2025
Increased Cardiovascular Risk With Lorlatinib in Patients With ALK-Mutated Lung Cancer: A Real-World Comparative Study.

Chien-Yu Lin, Po-Lan Su, Chin-Wei Kuo

|Oct 23, 2025
Role of Novel Bispecific Antibodies and Immunotherapy in Non-Small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations.

Po-Lan Su, Peiran Xu, Chien-Chung Lin

|Apr 16, 2025
Deubiquitinase USP24 activated by IL-6/STAT3 enhances PD-1 protein stability and suppresses T cell antitumor response.

Hung-Chia Hsieh, Ming-Jer Young, Kuan-Yu Chen

|Mar 17, 2025
Multivariable model for predicting 5-year survival in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective study.

Qi-An Wang, I-Lin Tsai, Chien-Yu Lin

|Feb 18, 2025
Enhancing Lung Recovery: Inhaled Poly(lactic-co-glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology.

Huei-Han Zhang, Wen-Shuo Kuo, Pei-Yu Tu

|Sep 18, 2023
Navigating the challenges of invasive pulmonary aspergillosis in lung cancer treatment: a propensity score study.

Chin-Wei Kuo, Chien-Yu Lin, Sheng-Huan Wei

Pageof 3

Frequent Collaborators

7 joint publications

Po-Lan Su

2 joint publications

Chin-Wei Kuo

2 joint publications

Szu-Chun Yang

2 joint publications

Chien-Yu Lin